|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
12 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | A Note on the Number Needed to Treat |
Lesaffre, Emmanuel |
1999 |
20 | 5 |
p. 439-447 9 p. |
artikel |
|
| 2 | A Randomized Trial of Evidence-Based Outreach (EBOR) |
Freemantle, Nick |
1999 |
20 | 5 |
p. 479-492 14 p. |
artikel |
|
| 3 | Assessing the Quality of Randomized Trials |
Clark, Heather D |
1999 |
20 | 5 |
p. 448-452 5 p. |
artikel |
|
| 4 | Book review |
1999 |
20 | 5 |
p. 473-475 3 p. |
artikel |
||
| 5 | Book review |
1999 |
20 | 5 |
p. 472-473 2 p. |
artikel |
||
| 6 | Data Monitoring Committees and Interim Monitoring Guidelines |
Freidlin, Boris |
1999 |
20 | 5 |
p. 395-407 13 p. |
artikel |
|
| 7 | Design and Baseline Characteristics for the Aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II) |
Freedman, Barry I |
1999 |
20 | 5 |
p. 493-510 18 p. |
artikel |
|
| 8 | Determination of Power and Sample Size in the Design of Clinical Trials with Failure-Time Endpoints and Interim Analyses |
Gu, Minggao |
1999 |
20 | 5 |
p. 423-438 16 p. |
artikel |
|
| 9 | Discussion |
1999 |
20 | 5 |
p. 469-471 3 p. |
artikel |
||
| 10 | Editorial |
1999 |
20 | 5 |
p. 476-478 3 p. |
artikel |
||
| 11 | Why Analysis of Variance Is Inappropriate for Multiclinic Trials |
Salsburg, David |
1999 |
20 | 5 |
p. 453-468 16 p. |
artikel |
|
| 12 | Worst-Rank Score Analysis with Informatively Missing Observations in Clinical Trials |
Lachin, John M |
1999 |
20 | 5 |
p. 408-422 15 p. |
artikel |
12 gevonden resultaten